- Engineering and Physical
Sciences Research Council (EPSRC) awards money as part of £11.4M investment to
harness the UK’s Digital Manufacturing potential - Research project aims to help
reduce the time it takes to get new drugs to market thus reducing costs to
patients. - Work on the 4-year research project will commence in July 2018.
|
| Improving crystallisation processes for manufacturing vitamins |
Glasgow’s reputation
as a centre of innovation and cutting-edge research was underlined today (Monday
25 June) by the award of a £1.9m grant from the Engineering and Physical
Sciences Research Council (EPSRC) to two of the city’s leading Higher Education
institutions, for a project aimed at accelerating the delivery of new drugs to
patients.
as a centre of innovation and cutting-edge research was underlined today (Monday
25 June) by the award of a £1.9m grant from the Engineering and Physical
Sciences Research Council (EPSRC) to two of the city’s leading Higher Education
institutions, for a project aimed at accelerating the delivery of new drugs to
patients.
The money has been awarded
to ARTICULAR, a project led by the University of Strathclyde and EPSRC-funded
Future Manufacturing Research Hub in Continuous Manufacturing and Advanced
Crystallisation (CMAC) with The Glasgow School of Art’s School of Simulation
and Visualisation (SimVis) heading all the Augmented Reality/Virtual Reality
elements. The research team also includes Loughborough University and leading
Silicon Valley company, DAQRI, along
with The Cambridge Crystallographic Data Centre, Booth Welsh, Perceptive
Engineering Ltd. and Siemens.
to ARTICULAR, a project led by the University of Strathclyde and EPSRC-funded
Future Manufacturing Research Hub in Continuous Manufacturing and Advanced
Crystallisation (CMAC) with The Glasgow School of Art’s School of Simulation
and Visualisation (SimVis) heading all the Augmented Reality/Virtual Reality
elements. The research team also includes Loughborough University and leading
Silicon Valley company, DAQRI, along
with The Cambridge Crystallographic Data Centre, Booth Welsh, Perceptive
Engineering Ltd. and Siemens.
ARTICULAR is one of
seven projects around the UK which will share £11.4M of investment from EPSRC. It
will exploit advances in digital technology to help reduce the time it takes to
get new drugs to market by harnessing the potential of large data sets and Machine
Learning – techniques which enable computers to progressively improve
performance on a specific task.
seven projects around the UK which will share £11.4M of investment from EPSRC. It
will exploit advances in digital technology to help reduce the time it takes to
get new drugs to market by harnessing the potential of large data sets and Machine
Learning – techniques which enable computers to progressively improve
performance on a specific task.
It is currently difficult to avoid ‘starting
at the beginning’ for every new drug that needs to be manufactured but new
medicines are currently doubling in cost every nine years. ARTICULAR seeks to
develop novel machine learning approaches that learn from past and present
manufacturing data to create new knowledge that aids in crucial manufacturing
decisions and lead to higher quality medicines for patients.
at the beginning’ for every new drug that needs to be manufactured but new
medicines are currently doubling in cost every nine years. ARTICULAR seeks to
develop novel machine learning approaches that learn from past and present
manufacturing data to create new knowledge that aids in crucial manufacturing
decisions and lead to higher quality medicines for patients.
Digital tools will be
created to make the design and manufacture of new medicines as efficient as
possible, thus helping to reduce the costs of bringing the medicines to
patients.
created to make the design and manufacture of new medicines as efficient as
possible, thus helping to reduce the costs of bringing the medicines to
patients.
|
| tailor-made crystals of Paracetamol for better performance in patients. |
Principal Investigator
for ARTICULAR, Dr Blair Johnston, Reader at Strathclyde
Institute of Pharmacy and Biomedical Sciences, said:
for ARTICULAR, Dr Blair Johnston, Reader at Strathclyde
Institute of Pharmacy and Biomedical Sciences, said:
“The University of
Strathclyde is pleased to be continuing its successful collaborations with The Glasgow
School of Art and Loughborough University. Our partners will bring world-class,
wide-ranging expertise to the ARTICULAR project to realise a data-driven,
machine learning future for medicine development and manufacturing.”
Strathclyde is pleased to be continuing its successful collaborations with The Glasgow
School of Art and Loughborough University. Our partners will bring world-class,
wide-ranging expertise to the ARTICULAR project to realise a data-driven,
machine learning future for medicine development and manufacturing.”
“CMAC is a leader in
the research and development of new methodologies and processes for the
manufacture of medicines and the ARTICULAR project will help us to achieve
these goals by integrating state-of-the-art computational methods and data
visualisation approaches to further enhance development and the availability of
high-quality treatments for any number of diseases.”
the research and development of new methodologies and processes for the
manufacture of medicines and the ARTICULAR project will help us to achieve
these goals by integrating state-of-the-art computational methods and data
visualisation approaches to further enhance development and the availability of
high-quality treatments for any number of diseases.”
“The use of advanced data
analytics is now commonplace in numerous other sectors and we look forward to
developing and demonstrating these applications with pharmaceutical industry partners
over the coming years.”
analytics is now commonplace in numerous other sectors and we look forward to
developing and demonstrating these applications with pharmaceutical industry partners
over the coming years.”
“The School of
Simulation and Visualisation (SimVis) is delighted to be continuing its
successful collaborations with the University of Strathclyde and their
world-class future manufacturing hub for research and training at CMAC,” adds Professor Paul Chapman, Head of
GSA SimVis.
Simulation and Visualisation (SimVis) is delighted to be continuing its
successful collaborations with the University of Strathclyde and their
world-class future manufacturing hub for research and training at CMAC,” adds Professor Paul Chapman, Head of
GSA SimVis.
“Within the ARTICULAR project, SimVis will
lead on the development of bespoke virtual and augmented reality tools which
will improve our understanding of complex pharmaceutical manufacturing
processes and data.
lead on the development of bespoke virtual and augmented reality tools which
will improve our understanding of complex pharmaceutical manufacturing
processes and data.
“Using our unique
AR/VR tools coupled with Daqri Smart Glasses and HTC Vives, we will add
data-rich interactive visualisations to help researchers in their work,
including providing a real-time virtual walk through of their laboratories.
AR/VR tools coupled with Daqri Smart Glasses and HTC Vives, we will add
data-rich interactive visualisations to help researchers in their work,
including providing a real-time virtual walk through of their laboratories.
“This award again recognises SimVis as a
leader in the field of immersive environments and demonstrates our creativity in
combining the arts and sciences.”
leader in the field of immersive environments and demonstrates our creativity in
combining the arts and sciences.”
Work on the 4-year research project will
commence in July 2018.
commence in July 2018.
Ends
For further information on Strathclyde University Institute of
Pharmacy and Biomedical Sciences contact:
Pharmacy and Biomedical Sciences contact:
Media and Corporate Communications
University of Strathclyde
T: + 44 (0) 141 548 2370
For further information on the GSA / SimVis contact
Lesley Booth,
07799414474
press@gsa.ac.uk
For further
information on the ESPRC contact the EPSRC Press Office on
01793 444404 or email pressoffice@epsrc.ukri.org
information on the ESPRC contact the EPSRC Press Office on
01793 444404 or email pressoffice@epsrc.ukri.org
Notes for Editors
ARTICULAR: ARtificial inTelligence for
Integrated ICT-enabled pharmaceUticaL mAnufactuRing – EP/R032858/1
Integrated ICT-enabled pharmaceUticaL mAnufactuRing – EP/R032858/1
Led by: Dr Blair Johnston, University of Strathclyde
Partners: The Glasgow School of Art, Loughborough University,
Arcinova, Booth Welsh, Cambridge Crystallographic Data Centre, DAQRI,
Perceptive Engineering Ltd, Siemens plc.
Arcinova, Booth Welsh, Cambridge Crystallographic Data Centre, DAQRI,
Perceptive Engineering Ltd, Siemens plc.
The University of Strathclyde
For
more than 200 years, the University of Strathclyde has been meeting the needs
of students, employers, industry and wider society through world-class
research, teaching, innovation and enterprise. Today, as a leading
international technological University, Strathclyde works side-by-side with
business, industry, government and the public sector, to improve health,
safeguard the future of energy supplies, set new standards in manufacturing,
and pioneer technologies. Its entrepreneurial environment makes Strathclyde
the partner of choice for growing numbers of organisations across the world,
and has been recognised through the award of Times Higher Education UK Business
School of the Year, Entrepreneurial University of the Year, and University of
the Year.
more than 200 years, the University of Strathclyde has been meeting the needs
of students, employers, industry and wider society through world-class
research, teaching, innovation and enterprise. Today, as a leading
international technological University, Strathclyde works side-by-side with
business, industry, government and the public sector, to improve health,
safeguard the future of energy supplies, set new standards in manufacturing,
and pioneer technologies. Its entrepreneurial environment makes Strathclyde
the partner of choice for growing numbers of organisations across the world,
and has been recognised through the award of Times Higher Education UK Business
School of the Year, Entrepreneurial University of the Year, and University of
the Year.
The Glasgow School of Art
The Glasgow School
of Art (GSA) was founded in 1845 as one of the first Government Schools of
Design, as a centre of creativity promoting good design for the manufacturing
industries of Glasgow. However, the School’s lineage can be traced to
1753 when Robert Foulis established a school of art and design in Glasgow,
which was described as the single most influential factor in the development of
eighteenth-century Scottish Art. Today, The GSA is internationally recognised
as one of Europe’s leading university-level institutions for the visual
creative disciplines. Our studio-based approach to research and teaching brings
disciplines together to explore problems in new ways to find innovative
solutions. The studio creates the environment for inter-disciplinary working,
peer learning, critical inquiry, experimentation and prototyping, helping to
addressing many of the great challenges confronting society and contemporary
business.
of Art (GSA) was founded in 1845 as one of the first Government Schools of
Design, as a centre of creativity promoting good design for the manufacturing
industries of Glasgow. However, the School’s lineage can be traced to
1753 when Robert Foulis established a school of art and design in Glasgow,
which was described as the single most influential factor in the development of
eighteenth-century Scottish Art. Today, The GSA is internationally recognised
as one of Europe’s leading university-level institutions for the visual
creative disciplines. Our studio-based approach to research and teaching brings
disciplines together to explore problems in new ways to find innovative
solutions. The studio creates the environment for inter-disciplinary working,
peer learning, critical inquiry, experimentation and prototyping, helping to
addressing many of the great challenges confronting society and contemporary
business.
The School of
Simulation and Visualisation (SimVis)
Simulation and Visualisation (SimVis)
The School of
Simulation and Visualisation (SimVis) currently specialises in postgraduate
teaching and research. It has been a leader in research and development within
the field of high-end 3D simulation and visualisation since 1997.Working with
EU and UK Research Councils, Government departments and blue-chip companies,
SimVis has created advanced visualisation products in various industries
including the automotive, built environment, defence, shipbuilding and medical
sectors. SimVis has a strong background in the medical visualisation sector,
and has produced 3D digital models of selected anatomy to support activities
such as pre-operative planning, risk reduction, surgical simulation and
increased patient safety.
Simulation and Visualisation (SimVis) currently specialises in postgraduate
teaching and research. It has been a leader in research and development within
the field of high-end 3D simulation and visualisation since 1997.Working with
EU and UK Research Councils, Government departments and blue-chip companies,
SimVis has created advanced visualisation products in various industries
including the automotive, built environment, defence, shipbuilding and medical
sectors. SimVis has a strong background in the medical visualisation sector,
and has produced 3D digital models of selected anatomy to support activities
such as pre-operative planning, risk reduction, surgical simulation and
increased patient safety.
SimVis is a partner
in the CCDV (with Historic Environment Scotland) which has delivered the
admired Scottish 10 and is delivering 3D models of Scotland’s most recent UNESO
World Heritage site, the Forth Bridge. SimVis also created the award-winning 3D
visualisations and soundscapes for the state of the art digital battle scenes
as part of the transformation of visitor facility to mark the 700th anniversary
of the Battle of Bannockburn in 2014 and last year announced a partnership with
Tennent’s to work on the company’s new visitor centre.
in the CCDV (with Historic Environment Scotland) which has delivered the
admired Scottish 10 and is delivering 3D models of Scotland’s most recent UNESO
World Heritage site, the Forth Bridge. SimVis also created the award-winning 3D
visualisations and soundscapes for the state of the art digital battle scenes
as part of the transformation of visitor facility to mark the 700th anniversary
of the Battle of Bannockburn in 2014 and last year announced a partnership with
Tennent’s to work on the company’s new visitor centre.
The Engineering and Physical Sciences
Research Council (EPSRC) is part of UK Research and
Innovation, a non-departmental public body funded by a grant-in-aid from the UK
government.
Research Council (EPSRC) is part of UK Research and
Innovation, a non-departmental public body funded by a grant-in-aid from the UK
government.
EPSRC is the main funding body for engineering and
physical sciences research in the UK. By investing in research and postgraduate
training, we are building the knowledge and skills base needed to address the
scientific and technological challenges facing the nation.
physical sciences research in the UK. By investing in research and postgraduate
training, we are building the knowledge and skills base needed to address the
scientific and technological challenges facing the nation.
Our portfolio covers a vast range of fields from
healthcare technologies to structural engineering, manufacturing to
mathematics, advanced materials to chemistry. The research we fund has impact
across all sectors. It provides a platform for future UK prosperity by
contributing to a healthy, connected, resilient, productive nation.
healthcare technologies to structural engineering, manufacturing to
mathematics, advanced materials to chemistry. The research we fund has impact
across all sectors. It provides a platform for future UK prosperity by
contributing to a healthy, connected, resilient, productive nation.